DRUG: Bright Minds Biosciences Inc.
Performance
DRUG -58.99%
Watchlist
Select an item
Summary
DRUG at a glance
DRUG returned -58.99% over the past year and -5.39% a year over five years. Its worst drop in that year was -80.25%, smaller than 2% of stocks on Redstone, and its Sharpe ratio of -0.57 beats 10% of stocks on Redstone. It pays no dividends.
Current Drawdown
-74.88%
Rolling Volatility
207.29%
Actions
Metrics
Risk Indicators
Alpha-61.44%
Beta1.29x
Sharpe-0.57
Sortino-0.70
Omega0.89
Calmar-0.74
Martin-1.83
Profile
About DRUG
Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain.
- Sector
- Health Care
- Market cap
- $238M
- Listed
- Mar 2021
- Employees
- 25
- Website
- brightmindsbio.com
Comparisons